DOJ charges two in counterfeit Ozempic smuggling scheme from China
Swapnadip Roy and Vicky Ramancha allegedly kept selling fake semaglutide pens to US distributors after FDA's December 2023 seizure and warning.
DO
By Daniel Okafor · Regulatory Correspondent
Sep 30 10:09 ETSource: Drugs.com
The wire
- 01Federal prosecutors in Florida charged two Indian citizens with conspiracy and smuggling over fake Ozempic bought from unapproved Chinese suppliers between July 2023 and April 2024.
- 02Counterfeit pens came with phony boxes, labels, needles and inserts sold at steep discounts to US distributors; FDA warns fakes may contain wrong or no active drug and non-sterile needles.
- 03An indictment is only an accusation. FDA warned again in December 2025 about fake 1 mg pens bearing real lot number PAR1229, distinguishable by EXP/LOT text placement.
From the source
Read at drugs.comTwo Charged In Scheme To Sell Counterfeit Ozempic — How You Can Spot Fake Meds
WEDNESDAY, Sept. 30, 2026 — Federal prosecutors have charged two people in an alleged scheme to bring fake versions of the type 2 diabetes drug Ozempic from China and sell them to U.S. distributors. Swapnadip Roy, 33, and Vicky Ramancha, 37...
